Nilandron
| Nilandron | |
|---|---|
| Term | Nilandron |
| Short definition | NIH - A federal agency in the United States that conducts biomedical research in its own laboratories; supports research by non-federal scientists at universities, medical schools, hospitals and research institutions at home and abroad; helps train researchers; and promotes the communication of medical information. Access the NIH website at |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Nilandron - (pronounced) (nih-LAN-drun) drug used to treat prostate cancer that has spread to other parts of the body. It is used in patients who have had an operation (orchiectomy) on their testicles. Nilandrone binds to proteins called androgen receptors found in some prostate cancer cells. These proteins bind to androgens (male hormones) and can cause cancer cells to grow. Nilandrone blocks these proteins and can prevent cancer cells from growing. It's a type of antiandrogen. Also called nilutamide
External links
- Medical encyclopedia article on Nilandron
- Wikipedia's article - Nilandron
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski